- Home
- PSNY vs CNTA Comparison
PSNY vs CNTA Comparison
Compare PSNY & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNY
- CNTA
- Stock Information
- Founded
- PSNY 2017
- CNTA 2020
- Country
- PSNY Sweden
- CNTA United Kingdom
- Employees
- PSNY N/A
- CNTA N/A
- Industry
- PSNY Auto Manufacturing
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- PSNY Consumer Discretionary
- CNTA Health Care
- Exchange
- PSNY Nasdaq
- CNTA Nasdaq
- Market Cap
- PSNY 2.8B
- CNTA 2.3B
- IPO Year
- PSNY N/A
- CNTA 2021
- Fundamental
- Price
- PSNY $1.00
- CNTA $17.16
- Analyst Decision
- PSNY Hold
- CNTA Strong Buy
- Analyst Count
- PSNY 8
- CNTA 7
- Target Price
- PSNY $1.59
- CNTA $23.71
- AVG Volume (30 Days)
- PSNY 6.0M
- CNTA 705.7K
- Earning Date
- PSNY 02-10-2025
- CNTA 11-12-2024
- Dividend Yield
- PSNY N/A
- CNTA N/A
- EPS Growth
- PSNY N/A
- CNTA N/A
- EPS
- PSNY N/A
- CNTA N/A
- Revenue
- PSNY $2,046,740,000.00
- CNTA $6,853,000.00
- Revenue This Year
- PSNY $40.97
- CNTA N/A
- Revenue Next Year
- PSNY $94.45
- CNTA N/A
- P/E Ratio
- PSNY N/A
- CNTA N/A
- Revenue Growth
- PSNY N/A
- CNTA N/A
- 52 Week Low
- PSNY $0.61
- CNTA $6.65
- 52 Week High
- PSNY $2.56
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- PSNY 44.02
- CNTA 50.89
- Support Level
- PSNY $0.85
- CNTA $16.02
- Resistance Level
- PSNY $1.21
- CNTA $18.12
- Average True Range (ATR)
- PSNY 0.07
- CNTA 1.08
- MACD
- PSNY -0.01
- CNTA -0.08
- Stochastic Oscillator
- PSNY 41.10
- CNTA 41.42
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.